Healthcare and Medical

Global Artificial Intelligence in Drug Screening Market Report, Latest Trends, Industry Opportunity & Forecast

Manya Gauutam

Global Artificial Intelligence in Drug Screening Market Report, Latest Trends, Industry Opportunity & Forecast

The global Artificial Intelligence in Drug Screening Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast. Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence in drug screening market include IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Get more information on "Global Artificial Intelligence in Drug Screening Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/artificial-intelligence-in-drug-screening-market/download-sample

Market Dynamics

The major factor driving the artificial intelligence in drug screening market growth includes an increase in alcohol consumption worldwide, a rise in the use of narcotics and illicit drugs across the globe, stringent government laws for drug screening, a rise in the adoption of AI systems, and technological innovations in the field of drug screening. Moreover, the market is expected to witness exponential growth during the forecast period, owing to the benefits of using these advanced techniques over traditional procedures. Furthermore, artificial intelligence reduces the cost and time utilized in the drug discovery process and boosts market growth. In addition, an increase in awareness related to artificial intelligence is expected to provide significant profitable opportunities for manufacturers in artificial intelligence for the drug screening industry. However, the shortage of the AI workforce and lack of data sets in the field of drug screening are some of the factors expected to hamper the market growth.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence in drug screening. The growth and trends of artificial intelligence in drug screening industry provide a holistic approach to this study.

Browse Global Artificial Intelligence in Drug Screening Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/artificial-intelligence-in-drug-screening-market

Market Segmentation

This section of the artificial intelligence in drug screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

· Deep Learning

· Machine Learning

By Drug Type

· Small Molecule

· Large Molecules

By Disease Type

· Metabolic Disease

· Cardiovascular Disease

· Oncology

· Neurodegenerative Diseases

· Others

By End-Users

· Pharmaceutical Companies

· Biopharmaceutical Companies

· Academic And Research Institutes

· Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence in Drug Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Purchase Complete Global Artificial Intelligence in Drug Screening Market Research Report at https://www.valuemarketresearch.com/contact/artificial-intelligence-in-drug-screening-market/buy-now

About Us:

Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.

We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:

Value Market Research

401/402, TFM, Nagras Road, Aundh, Pune-7.

Maharashtra, INDIA.

Tel: +1-888-294-1147

Email: [email protected]

Website: https://www.valuemarketresearch.com

Manya Gauutam

Artificial Intelligence in Drug Discovery Market Is Estimated To Witness High Growth Owing To Increasing Adoption of AI in Drug Discovery

Ben Wood 2023-09-12

The global Artificial Intelligence in Drug Discovery Market is estimated to be valued at US$ 1,016. This enables researchers to accelerate the drug discovery process and identify potential drug candidates with higher success rates. PEST Analysis: Political: The political factors affecting the Artificial Intelligence in Drug Discovery Market include government regulations and policies related to drug development and approval. The increasing adoption of AI technologies in the healthcare industry for drug discovery, drug repurposing, and precision medicine is expected to fuel market growth. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the Artificial Intelligence in Drug Discovery Market.

Artificial Intelligence in Computational Biology is fastest growing segment fueling the growth of Artificial Intelligence in Drug Discovery Market

Sumedha 2023-12-06

The Artificial Intelligence in Drug Discovery market is estimated to be valued at US$ 1,266. This is another factor fueling market growth. SWOT Analysis Strength: Artificial intelligence in drug discovery utilize algorithms and large data sets to identify potential drug candidates, reducing costs and saving time in R&D. Key Takeaways: The Global Artificial Intelligence in Drug Discovery Market Share is expected to witness high growth, exhibiting CAGR of 5. Key players operating in the Artificial Intelligence in Drug Discovery are IBM Corporation (IBM Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc.

Artificial Intelligence (AI) In Drug Discovery Market 2022 - Estimated Yield, Demand And Revenue Analysis

Biswadeep 2022-05-09

id=3411&type=smp The global artificial intelligence in drug discovery market size is expected to grow from $0. com/report/artificial-intelligence-in-drug-discovery-global-market-report The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022-31 by The Business Research Company evaluates artificial intelligence in drug discovery market size, growth rate, drivers, artificial intelligence in drug discovery industry trends, and major companies. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery Market5. Key Mergers And Acquisitions Of The Artificial Intelligence (AI) In Drug Discovery Market 29. Future Outlook and Potential Analysis Of The Artificial Intelligence (AI) In Drug Discovery Market About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.

Drug Discovery techonogy Market Report 2024: Growth Rate, Major Segments And Regions

saikiran TBRC 2024-03-10

Learn More On The Artificial Intelligence (AI) In Drug Discovery Market:https://www. The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. The growing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) in drug discovery market going forward. Thus, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) in drug discovery market. The artificial intelligence (ai) in drug discovery market report table of contents includes:1.

Drug Screening Market to Witness Massive Growth by 2029 :LabCorp, Quest Diagnostics, Abbott Laboratories

Revati Raje 2022-11-08

The Drug Screening Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 17% during the review period (2020 to 2029). Each section of the research study is specially prepared to explore key aspects of the global Drug Screening market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global market. Get Sample Pages PDF (Including Full TOC, Table & Figures) https://exactitudeconsultancy. com/reports/8956/drug-screening-market/#request-a-sampleCompetitors in Drug Screening Market Report Are LabCorp, Quest Diagnostics, Abbott Laboratories, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, MPD Inc.

Jignesh Jariwala 2022-09-23

has added a new report titled, ‘Artificial Intelligence ( AI ) in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecasts, 2022 - 2027’ to its vast repository of research reports. The global Artificial Intelligence ( AI ) in Drug Discovery market was estimated at USD 0. Companies covered:Some of the key players in AI in Drug Discovery Market are Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrödinger (US), Atomwise, Inc. id=151193446The study categorizes the AI in drug discovery market into the following segments and subsegments:AI in drug discovery market, By Offering· Software· ServicesAI in drug discovery market, By Technology· Machine Learning· Deep Learning· Supervised Learning· Reinforcement Learning· Unsupervised Learning· Other Machine Learning Technologies· Other TechnologiesAI in drug discovery market, by Application· Immuno-oncology· Neurodegenerative diseases· Cardiovascular diseases· Metabolic diseases· Other ApplicationsAI in drug discovery market, By End User· Pharmaceutical & biotechnology companies· Contract research organizations· Research centers and academic & government institutesSome of the key geographies mentioned in this report include:· North America (U. S and Canada and rest of North America)· Europe (Germany, France, Italy, and Rest of Europe)· Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)· LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)Key questions answered in the report· What will be the market size and growth rate by the end of the forecast period?

WHO TO FOLLOW